Sort
40,608 grants matching “prostate cancer”
Characterizing a Common Degradation Pathway for Nuclear Hormone Receptors
$447,500Jonathan Michael Tsai · Brigham And Women'S Hospital · DP5 · FY2025 · OD
Characterizing a Common Degradation Pathway for Nuclear Hormone Receptors
$447,500Jonathan Michael Tsai · Brigham And Women'S Hospital · DP5 · FY2023 · OD
Characterizing a Common Degradation Pathway for Nuclear Hormone Receptors
$447,500Jonathan Michael Tsai · Brigham And Women'S Hospital · DP5 · FY2024 · OD
Molecular Mechanisms of Complex Mixture Toxicity
$447,496Alvaro Puga · University Of Cincinnati · R01 · FY2014 · ES
Ponce School of Medicine - Moffitt Cancer Center Partnership
$447,454Warren Jackson Pledger · H. Lee Moffitt Cancer Ctr & Res Inst · U56 · FY2008 · CA
Interplay between tumor and microenvironment in bone metastasis
$447,407Paul B Fisher · Virginia Commonwealth University · R01 · FY2024 · CA
Developmental transcription factors in Drosha-driven cancer
$447,405Kenneth Sung-Man Chen · Ut Southwestern Medical Center · R01 · FY2024 · CA
Multifunctional immunoPET tracers for pancreatic and prostate cancer
$447,370Anna M Wu · University Of California Los Angeles · R01 · FY2015 · CA
Multifunctional immunoPET tracers for pancreatic and prostate cancer
$447,370Anna M Wu · University Of California Los Angeles · R01 · FY2013 · CA
Defining the role of macropinocytosis in solid tumor growth and therapeutic resistance
$447,367Aimee L Edinger · University Of California-Irvine · R01 · FY2023 · CA
Treatment-Induced Phenotypic Reprogramming in Prostate Cancer
$447,321Natasha Kyprianou · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Treatment-Induced Phenotypic Reprogramming in Prostate Cancer
$447,318Natasha Kyprianou · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA
Improving Quality of Life of Prostate Cancer Survivors with Androgen Deficiency
$447,317Shalendar Bhasin · Brigham And Women'S Hospital · R01 · FY2023 · AG
Bioluminescence and Fluorescence Optical Animal Imager
$447,288Guillermo Marques · University Of Minnesota · S10 · FY2022 · OD
LABOR MARKET OUTCOMES OF LONG TERM CANCER SURVIVORS
$447,199Michigan State University · R01 · FY2001 · CA
PROSTATE, LUNG, COLORECTAL &OVARIAN CANCER
$447,194Georgetown University · N01 · FY2000 · CN
Tissue/Informatics
$447,171Lakshmi Priya Kunju · University Of Michigan At Ann Arbor · P50 · FY2016 · CA
Fine mapping and characterization of the 8q24 prostate cancer risk locus
$447,130Matthew L Freedman · Dana-Farber Cancer Inst · R01 · FY2009 · CA
Microfluidic Platform for Preparation of Biomolecule Based Nuclear Imaging Probes
$447,065David E. Reichert · Washington University · R01 · FY2011 · CA
Compact registration-free robotic tool guide for image guided percutaneous interventions
$447,000Sangeun Song · University Of Central Florida · R15 · FY2020 · EB
Enhanced delivery of site-specific DNA damaging toxins to prostate cancercells
$447,000Sridhar Varadarajan · University Of North Carolina Wilmington · R15 · FY2023 · CA
Biomarker Reference Laboratory, EDRN
$446,996William E. Grizzle · University Of Alabama At Birmingham · U24 · FY2009 · CA
BIOMAKERS DEVELOPMENT LABORATORY
$446,945University Of Washington · U01 · FY2003 · CA
PRE-VIEW An Interactive Video Doctor to Encourage Cancer Screening
$446,878Judith Mary Eileen Walsh · University Of California, San Francisco · R01 · FY2014 · CA
CANCER AWARENESS NETWORK FOR IMMIGRANT MINORITY POPULATI
$446,849New York University School Of Medicine · U01 · FY2002 · CA